Payden & Rygel Reduces Stock Holdings in Cigna Group $CI

Payden & Rygel lowered its stake in Cigna Group (NYSE:CI) by 25.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 29,000 shares of the health services provider’s stock after selling 9,800 shares during the period. Payden & Rygel’s holdings in Cigna Group were worth $7,982,000 at the end of the most recent reporting period.

A number of other hedge funds have also added to or reduced their stakes in the stock. Northwestern Mutual Wealth Management Co. lifted its position in shares of Cigna Group by 13,333.2% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 3,165,408 shares of the health services provider’s stock worth $900,912,000 after purchasing an additional 3,141,844 shares during the period. Capital Research Global Investors increased its position in shares of Cigna Group by 140.2% during the third quarter. Capital Research Global Investors now owns 3,179,301 shares of the health services provider’s stock valued at $916,434,000 after buying an additional 1,855,897 shares during the period. Massachusetts Financial Services Co. MA raised its stake in Cigna Group by 8.3% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 11,805,083 shares of the health services provider’s stock worth $3,249,113,000 after buying an additional 903,334 shares in the last quarter. Ameriprise Financial Inc. raised its stake in Cigna Group by 54.5% in the third quarter. Ameriprise Financial Inc. now owns 2,136,311 shares of the health services provider’s stock worth $615,781,000 after buying an additional 753,865 shares in the last quarter. Finally, M&T Bank Corp lifted its holdings in Cigna Group by 1,299.3% in the fourth quarter. M&T Bank Corp now owns 635,706 shares of the health services provider’s stock worth $174,965,000 after buying an additional 590,277 shares during the period. 86.99% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research analysts have weighed in on the company. Raymond James Financial set a $340.00 target price on Cigna Group in a report on Friday, May 1st. Mizuho set a $330.00 target price on Cigna Group in a research note on Friday, May 1st. Cantor Fitzgerald lifted their price target on Cigna Group from $325.00 to $340.00 and gave the company an “overweight” rating in a research report on Friday, May 1st. TD Cowen upped their price target on Cigna Group from $333.00 to $338.00 and gave the stock a “buy” rating in a research note on Monday, February 9th. Finally, Deutsche Bank Aktiengesellschaft increased their price objective on Cigna Group from $301.00 to $304.00 and gave the stock a “buy” rating in a report on Tuesday, February 10th. One research analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $338.35.

Cigna Group Trading Up 0.3%

Cigna Group stock opened at $286.14 on Tuesday. Cigna Group has a one year low of $239.51 and a one year high of $338.89. The business’s fifty day moving average is $275.05 and its 200 day moving average is $275.57. The stock has a market capitalization of $75.69 billion, a PE ratio of 12.13, a price-to-earnings-growth ratio of 1.00 and a beta of 0.30. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.73 and a quick ratio of 0.73.

Cigna Group (NYSE:CI) last issued its earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, topping analysts’ consensus estimates of $7.60 by $0.19. The business had revenue of $68.52 billion during the quarter, compared to analyst estimates of $66.29 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.Cigna Group’s revenue was up 4.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned $6.74 EPS. Cigna Group has set its FY 2026 guidance at 30.350- EPS. On average, sell-side analysts predict that Cigna Group will post 30.39 EPS for the current year.

Cigna Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, June 18th. Investors of record on Thursday, June 4th will be given a dividend of $1.56 per share. The ex-dividend date is Thursday, June 4th. This represents a $6.24 dividend on an annualized basis and a yield of 2.2%. Cigna Group’s dividend payout ratio is 26.45%.

Insider Buying and Selling

In related news, CEO David Cordani sold 201,878 shares of the firm’s stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total value of $59,113,915.96. Following the sale, the chief executive officer owned 34,337 shares in the company, valued at approximately $10,054,560.34. This trade represents a 85.46% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nicole S. Jones sold 2,307 shares of Cigna Group stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $666,515.37. Following the completion of the sale, the insider directly owned 32,647 shares of the company’s stock, valued at approximately $9,432,044.77. This trade represents a 6.60% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders have sold 205,904 shares of company stock worth $60,277,068. 0.60% of the stock is owned by insiders.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.